The possible mechanisms of action of (-)deprenyl in Parkinson's disease

This publication has 32 references indexed in Scilit:

• Novel (−)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action
  Biochemical Pharmacology, 1978
• IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE
  The Lancet, 1977
• Dopamine is a monoamine oxidase B substrate in man
  Nature, 1977
• The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas
  Neuropharmacology, 1976
• Analysis of the Pharmacological Effects of Selective Monoamine Oxidase Inhibitors
  Published by Wiley ,1976
• The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation
  European Journal of Pharmacology, 1975
• The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
• Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system
  Brain Research, 1975
• Monoamine oxidase inhibitors and L-dopa.
  BMJ, 1970
• The Chemical Approach to the Control of Tuberculosis
  Science, 1952